Back to news

MiniMed slips as split-off mechanics and fresh analyst caution weigh on shares

Investivoq PriceTracker

MiniMed Group (MMED) is down 4.0% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver appears to be pressure tied to Medtronic’s split-off of MiniMed, which has increased focus on share supply, exchange-offer mechanics, and near-term repositioning by investors. A fresh Hold initiation also may be limiting buying interest, especially since there does not appear to be a new company press release today that would offset that overhang.

Details:

  • Medtronic recently set the final exchange ratio for its MiniMed split-off at 4.5939 MiniMed shares for each Medtronic share accepted in the offer, keeping attention on transaction-driven trading.
  • The exchange materials contemplated up to 225,361,295 MiniMed shares in the offer, with Medtronic also indicating it could distribute its remaining interest if the deal was oversubscribed, which points to meaningful supply entering the market.
  • MiniMed had operated with Medtronic owning about 90% of the company after the March 2026 IPO, so the separation process materially changes the shareholder base and can create temporary selling pressure.
  • Jefferies initiated coverage with a Hold rating and a $22 price target on October 12, 2026, which may have reinforced a more cautious tone around the stock.

    • Sources:

    SEC, Medtronic, Investing.com ([sec.gov](https://www.sec.gov/Archives/edgar/data/2062583/000162828026061669/mdt-20260914.htm?utm_source=openai))

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    EARLY ACCESS
    Receive MMED Data Alerts
    Real-time alerts on filings, insider trades, and market signals — before everyone else.
    Get Alerts →

    $MMED Hedge Fund Activity

    We have seen 72 institutional investors add shares of $MMED stock to their portfolio, and 26 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    • ALYESKA INVESTMENT GROUP, L.P. removed 2,000,000 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $29,900,000
    • BLACKROCK, INC. added 1,970,314 shares (+7527.5%) to their portfolio in Q2 2026, for an estimated $29,456,194
    • NORGES BANK added 1,961,002 shares (+inf%) to their portfolio in Q2 2026, for an estimated $29,316,979
    • HOOD RIVER CAPITAL MANAGEMENT LLC removed 1,505,778 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $22,511,381
    • MASSACHUSETTS FINANCIAL SERVICES CO /MA/ added 1,456,278 shares (+21.2%) to their portfolio in Q2 2026, for an estimated $21,771,356
    • EXODUSPOINT CAPITAL MANAGEMENT, LP added 1,437,067 shares (+inf%) to their portfolio in Q2 2026, for an estimated $21,484,151
    • POINT72 ASSET MANAGEMENT, L.P. removed 1,124,398 shares (-98.6%) from their portfolio in Q2 2026, for an estimated $16,809,750

    To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.

    $MMED Price Targets

    Multiple analysts have issued price targets for $MMED recently. We have seen 3 analysts offer price targets for $MMED in the last 6 months, with a median target of $20.0.

    Here are some recent targets:

    • Larry Biegelsen from Wells Fargo set a target price of $22.0 on 06/04/2026
    • Travis Steed from B of A Securities set a target price of $20.0 on 05/18/2026
    • Bruce Jackson from Benchmark set a target price of $20.0 on 05/12/2026

    This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.